SCA
PBE icon

Stonebridge Capital Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Stonebridge Capital Advisors’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$5.7K – 654
2023
Q3 		$5.7K Hold
100
– – ﹤0.01% 689
2023
Q2 		$6.13K Hold
100
– – ﹤0.01% 687
2023
Q1 		$6.28K Hold
100
– – ﹤0.01% 677
2022
Q4 		$6.35K Hold
100
– – ﹤0.01% 669
2022
Q3 		$6K Hold
100
– – ﹤0.01% 660
2022
Q2 		$6K Hold
100
– – ﹤0.01% 690
2022
Q1 		$6K Hold
100
– – ﹤0.01% 754
2021
Q4 		$7K Hold
100
– – ﹤0.01% 697
2021
Q3 		$7K Sell
100
-100
-50% -$7.62K ﹤0.01% 677
2021
Q2 		$15K Buy
200
+100
+100% +$7.43K ﹤0.01% 672
2021
Q1 		$7K Buy
+100
New +$7.56K ﹤0.01% 683
2020
Q3 		– Sell
-100
Closed -$6K – 552
2020
Q2 		$6K Hold
100
– – ﹤0.01% 553
2020
Q1 		$5K Hold
100
– – ﹤0.01% 562
2019
Q4 		$6K Hold
100
– – ﹤0.01% 626
2019
Q3 		$5K Hold
100
– – ﹤0.01% 625
2019
Q2 		$5K Buy
+100
New +$5.19K ﹤0.01% 675

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $938M AUM 29.36% 1-Year Est. Return

Stonebridge Capital Advisors's PBE Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2023, closing a stake of 100 shares — an estimated $5.7K sold.

Stonebridge Capital Advisors first reported a position in PBE in Q2 2019 and held it in 16 quarters. The position peaked at $15K in Q2 2021. 95 funds tracked by Wall St. Rank hold PBE as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 100 Invesco Biotechnology & Genome ETF shares in Q4 2023, an estimated $5.7K.
  • Stonebridge Capital Advisors first reported a position in Invesco Biotechnology & Genome ETF in Q2 2019 and held it in 16 quarters.
  • Stonebridge Capital Advisors's Invesco Biotechnology & Genome ETF position peaked at $15K in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.